These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 17443604

  • 1. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
    Petsky HL, Kynaston JA, Turner C, Li AM, Cates CJ, Lasserson TJ, Chang AB.
    Cochrane Database Syst Rev; 2007 Apr 18; (2):CD005603. PubMed ID: 17443604
    [Abstract] [Full Text] [Related]

  • 2. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
    Petsky HL, Li A, Chang AB.
    Cochrane Database Syst Rev; 2017 Aug 24; 8(8):CD005603. PubMed ID: 28837221
    [Abstract] [Full Text] [Related]

  • 3. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).
    Petsky HL, Cates CJ, Lasserson TJ, Li AM, Turner C, Kynaston JA, Chang AB.
    Thorax; 2012 Mar 24; 67(3):199-208. PubMed ID: 20937641
    [Abstract] [Full Text] [Related]

  • 4. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
    Petsky HL, Cates CJ, Li AM, Kynaston JA, Turner C, Chang AB.
    Cochrane Database Syst Rev; 2008 Apr 16; (2):CD006340. PubMed ID: 18425949
    [Abstract] [Full Text] [Related]

  • 5. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
    Petsky HL, Cates CJ, Li A, Kynaston JA, Turner C, Chang AB.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006340. PubMed ID: 19821360
    [Abstract] [Full Text] [Related]

  • 6. Exhaled nitric oxide levels to guide treatment for children with asthma.
    Petsky HL, Kew KM, Chang AB.
    Cochrane Database Syst Rev; 2016 Nov 09; 11(11):CD011439. PubMed ID: 27825189
    [Abstract] [Full Text] [Related]

  • 7. Exhaled nitric oxide levels to guide treatment for adults with asthma.
    Petsky HL, Kew KM, Turner C, Chang AB.
    Cochrane Database Syst Rev; 2016 Sep 01; 9(9):CD011440. PubMed ID: 27580628
    [Abstract] [Full Text] [Related]

  • 8. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005535. PubMed ID: 16235410
    [Abstract] [Full Text] [Related]

  • 9. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF, Chartrand C, Ducharme FM.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD009611. PubMed ID: 23235678
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ducharme FM, Lasserson TJ, Cates CJ.
    Cochrane Database Syst Rev; 2006 Oct 18; (4):CD003137. PubMed ID: 17054161
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005533. PubMed ID: 16235409
    [Abstract] [Full Text] [Related]

  • 15. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS, Cates CJ, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD003137. PubMed ID: 15674901
    [Abstract] [Full Text] [Related]

  • 16. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ, Lasserson TJ, Jaeschke R.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD006924. PubMed ID: 19370661
    [Abstract] [Full Text] [Related]

  • 17. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.
    Ng D, Salvio F, Hicks G.
    Cochrane Database Syst Rev; 2004 Apr 15; (2):CD002314. PubMed ID: 15106175
    [Abstract] [Full Text] [Related]

  • 18. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM, Greenstone IR, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Apr 18; (2):CD005307. PubMed ID: 15846751
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ, Lasserson TJ, Jaeschke R.
    Cochrane Database Syst Rev; 2009 Jul 08; (3):CD006922. PubMed ID: 19588410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.